In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
BTG grants LeukoSite exclusive rights to anti-D3 antibody technology
BTG expands vaccine technology portfolio
BTG to license 'light-switchable' technology
BTG to commercialise DHA enrichment technology
Cincinnati Children's Hospital Medical Center and BTG agree licence deal
PULSION grants PiCCO and CeVOX license to DIXTAL
BTG signs commercialisation agreement with leading US laboratory
BTG acquires compounds for treatment of cardiac and renal disease